dna-binding ELISAs for activated AML/Runx transcription factors
TransAM® Kits are DNA-binding ELISAs that facilitate the study of transcription factor activation in mammalian tissue and cell extracts. Assays are available for over 40 different targets (see the list at right). Each kit includes a 96-stripwell plate in which multiple copies of a specific double-stranded oligonucleotide have been immobilized. When nuclear or whole-cell extract is added, activated transcription factor of interest binds the oligonucleotide at its consensus binding site and is quantified using the included antibody, which is specific for the bound, active form of the transcription factor being studied. For complete details, click the TransAM® Method tab below.
TransAM® AML/Runx Transcription Factor ELISA Kits
TransAM AML-1/Runx1 and TransAM AML-3/Runx2 Kits provide everything needed to study activated AML-1/Runx1 or AML-3/Runx2, including a positive control extract. The AML-1/Runx1 kit can be used with human extracts, while the AML-3/Runx2 kit can be used with human, mouse and rat extracts. Click the AML Info tab below for data and more information; kit manuals can be downloaded under the Documents tab.
|TransAM® AML-1/Runx1||1 x 96 rxns||47396||$685||Buy Now|
|5 x 96 rxns||47896||$2,795||Buy Now|
|TransAM® AML-3/Runx2||1 x 96 rxns||44496||$685||Buy Now|
|5 x 96 rxns||44996||$2,795||Buy Now|
|TransAM® AML-1/Runx1 Manual|
|TransAM® AML-3/Runx2 Manual|
|Gene Regulation Products & Services Brochure|
|Tools for Disease Research|
|MSDS: Sodium Azide|
|MSDS: Sulphuric Acid|
AML/Runx Transcription Factor Info
AML/Runx factors are essential for blood, skeletal and gastric development and are composed of heterodimeric α and β subunits. In mammals, the α subunits are encoded by three genes, Runx1, 2 and 3, while the β subunit (PEBP2β, CBFβ) is ubiquitously expressed. AML-1/Runx1 is essential for definitive hematopoiesis and is one of the most frequently mutated genes in human leukemia development, while AML-3/Runx2 controls osteoblast differentiation and the development of hypertrophic cartilage. Mutations of AML-3 lead to the rare bone disease cleidocranial dysplasia (CCD) and are associated with human leukemia.
Figure 1: Monitoring AML-1/Runx1 activation with the TransAM AML-1/Runx1 Kit.
The TransAM® transcription factor ELISA advantage
Historically, transcription factor studies have been conducted using gelshift, Western blot and reporter plasmid transfections, which are time-consuming, do not allow for high-throughput and provide only semi-quantitative results. TransAM assays are up to 100 times more sensitive than gelshift techniques, and can be completed in less than 5 hours. Because TransAM is an ELISA-based assay*, there is no radioactivity, and the high-throughput stripwell format enables simultaneous screening of 1-96 samples. Inconsistencies due to variable reporter plasmid transfections are eliminated, along with the need to construct stable cell lines.
Why use TransAM® transcription factor ELISAs?
- Up to 100-fold more sensitive than gelshift assays
- Eliminates the use of radioactivity and the need to run gels
- Results in less than five hours
- Colorimetric readout enables easy, quantitative analysis with spectrophotometry at 450 nm
- 96-stripwell format enables both high and low throughput
How TransAM® transcription factor ELISAs work
The TransAM format is perfect for assaying transcription factor binding to a consensus-binding site. TransAM Kits contain a 96-stripwell plate to which the consensus-binding site oligo has been immobilized. Activated nuclear extract is added to each well and the transcription factor of interest binds specifically to this bound oligonucleotide. A primary antibody specific for an epitope on the bound and active form of the transcription factor is then added followed by subsequent incubation with secondary antibody and Developing Solution to provide an easily quantified, sensitive colorimetric readout (Figure 1).
Figure 1: Flow chart of the TransAM process.
Contents & Storage
One or five 96-well plate(s) with plate sealer(s), primary antibody, HRP-conjugated secondary antibody, wild-type and mutated oligonucleotides, positive control cell extract, DTT, Herring Sperm DNA, Protease Inhibitor Cocktail, Lysis, Binding, 10X Washing and 10X Antibody Binding Buffers, and Developing and Stop Solutions. Reagent storage conditions vary from room temperature to -80°C, see manual for details. All reagents are guaranteed stable for 6 months when stored properly.
|TransAM AML-1/Runx1: Catalog Number 44496|
|TransAM AML-1/Runx1: Catalog Number 44996|
|TransAM AML-1/Runx1: Catalog Number 47396|
|TransAM AML-1/Runx1: Catalog Number 47896|